Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Emerging strategies to effectively target autophagy in cancer
1The Department of Medicine and Abramson Cancer Center; University of Pennsylvania School of Medicine, Philadelphia, PA USA.
Abstract:
Autophagy serves a dichotomous role in cancer and recent advances have helped delineate the appropriate settings where inhibiting or promoting autophagy may confer therapeutic efficacy in patients. Our evolving understanding of the molecular machinery responsible for the tightly controlled regulation of this homeostatic mechanism has begun to bear fruit in the way of autophagy-oriented clinical trials and promising lead compounds to modulate autophagy for therapeutic benefit. In this manuscript we review the recent preclinical and clinical therapeutic strategies that involve autophagy modulation in cancer.
Insights
Autophagy can help or hinder cancer, depending on the context. New strategies now target autophagy modulation for cancer therapy, with ongoing clinical trials showing promise.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Homeostasis
Background:
- Autophagy plays a complex, dual role in cancer development and progression.
- Recent scientific breakthroughs are clarifying the specific conditions under which autophagy can be therapeutically targeted.
- Understanding the molecular regulation of autophagy is crucial for developing novel cancer treatments.
Purpose of the Study:
- To review current preclinical and clinical strategies for cancer therapy that involve modulating autophagy.
- To highlight the therapeutic potential of targeting the autophagy pathway in various cancers.
Main Methods:
- Review of recent preclinical research on autophagy modulation in cancer.
- Analysis of ongoing and completed clinical trials investigating autophagy-targeted therapies.
- Synthesis of data on lead compounds designed to modulate autophagy.
Main Results:
- Identification of specific cancer contexts where autophagy inhibition or promotion is beneficial.
- Evidence from preclinical studies supporting autophagy modulation as a viable therapeutic strategy.
- Emerging clinical data from autophagy-oriented trials indicating therapeutic efficacy.
Conclusions:
- Autophagy modulation represents a promising therapeutic avenue in oncology.
- Targeting autophagy offers potential for improved treatment outcomes in cancer patients.
- Further research and clinical trials are essential to fully realize the therapeutic benefits of autophagy modulation.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

